HS reduces the volume of intravenous fluid required to maintain patients undergoing surgery but transiently increases serum sodium. It is not known if HS effects patient survival and morbidity but it should be tested in randomized clinical trials that are designed and powered to test these outcomes.
[Use of a hypertonic solution of 7.5% NaCl in preventing post-declamping hypotension of the abdominal aorta].